Physician profile
Michael Robert George
NPI 1699966218
$1,889.97
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $178 · 2021: $277 · 2022: $316 · 2023: $336 · 2024: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $785.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $654.44 | 2019-2024 | Clareon, Wavelight Refractive Suite |
| Johnson & Johnson Surgical Vision, INC. | $246.41 | 2019-2023 | Tecnis Iol |
| Bausch & Lomb Americas INC. | $173.02 | 2022-2024 | Miebo, Vyzulta, Stellaris |
| Ocular Therapeutix, INC. | $104.55 | 2023-2024 | Dextenza |
| Novartis Pharmaceuticals Corporation | $98.60 | 2022-2023 | |
| Oyster Point Pharma, INC. | $92.67 | 2022-2024 | Tyrvaya, Ryzumvi |
| Stryker Corporation | $89.24 | 2021 | |
| Abbvie INC. | $58.95 | 2023-2024 | |
| Harrow Eye, LLC | $52.71 | 2024 | Vevye |
| Rayner Intraocular Lenses Limited | $46.42 | 2023-2024 | Rayone Spheric, Omidria, Rayone Emv |
| Rxsight INC | $39.89 | 2022-2023 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal) |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $37.03 | 2021 | |
| Sun Pharmaceutical Industries INC. | $26.44 | 2023 | Cequa |
| Kala Pharmaceuticals, INC. | $23.97 | 2022 | |
| Lombart Brothers, INC. | $23.27 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $21.86 | 2024 | Xdemvy |
| Thea Pharma INC. | $20.23 | 2023 | Iyuzeh |
| Carl Zeiss Meditec, INC. | $19.97 | 2021 | |
| Staar Surgical Company | $19.63 | 2019 | |
| Glaukos Corporation | $15.59 | 2020 | |
| Tearlab Corp | $13.70 | 2022 | |
| Katena Products, INC. (Dba Corza Medical) | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.